MORPHINE
morphine sulfate pentahydrate 15 mg/mL injection, 5 x 1 mL ampoules
MORPHINE (1645N)
1645N
Body System:
Manner of administration:Injection
Restriction
Indication: Severe pain
Treatment phase: Initial PBS treatment after 1 June 2020 where patient has been treated with opioids
for less than 12 months
Restriction
Indication: Severe pain
Treatment phase: Initial PBS treatment after 1 June 2020 where patient has been treated with opioids
for more than 12 months
Restriction
Indication: Severe pain
Treatment phase: Continuing PBS treatment after 1 June 2020
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 5 | # of repeats: 0 | DPMQ: $27.01 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| MORPHINE SULFATE 15 mg/1 mL MEDSURGE | |||||